NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球皮膚癌診斷和治療市場(2021-2027)

Skin Cancer Diagnosis and Therapeutics Market 2021-2027

出版商 Orion Market Research Pvt Ltd 商品編碼 1025422
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球皮膚癌診斷和治療市場(2021-2027) Skin Cancer Diagnosis and Therapeutics Market 2021-2027
出版日期: 2021年07月14日內容資訊: 英文
簡介

在預測期內,皮膚癌診斷和治療的市場規模預計將以約 7.5% 的顯著複合年增長率增長。預計該市場在預測期內將出現大幅增長。市場增長的主要因素是人造太陽燈的使用、強烈的紫外線 (UV) 照射以及由於使用日光浴床導致皮膚癌發病率增加。在 35 歲之前使用曬黑或日光浴床的人有 75% 的機會被診斷出患有黑色素瘤。隨著皮膚癌的發展,政府有利的努力、免疫療法和作為當前治療延伸的治療的數量也在增加。

然而,高昂的處理成本、嚴格監管的環境和低公眾意識會阻礙市場增長。根據美國癌症協會的數據,2021 年美國新診斷出 106,110 例侵襲性黑色素瘤和 101,280 例原位黑色素瘤,預計將有 7,180 人死於該病。根據世界衛生組織 (WHO) 的數據,到 2021 年,全球將有超過 120 萬人被診斷出患有非黑色素瘤癌症。

自 2019 年 12 月以來,COVID-19 對全球皮膚癌診斷和治療藥物市場產生了負面影響。市場在經濟上受到 COVID-19 的影響。 COVID-19 疫情暫時推遲了皮膚癌患者的治療和診斷。癌症患者的診斷和治療必須迅速進展。然而,在預測期內,人們對皮膚癌的興趣日益濃厚,預計將改善市場。

全球皮膚癌診斷和治療藥物市場按類型、治療、診斷和最終用戶分類。根據類型,皮膚癌診斷和治療藥物市場分為黑色素瘤和非黑色素瘤。根據療法,皮膚癌診斷和治療藥物市場分為手術、放射、化學療法、靶向療法、免疫療法等。根據診斷,皮膚癌診斷和治療藥物市場分為皮膚科、活檢、血液檢查、X射線檢查等。

全球皮膚癌診斷和治療藥物市場的估值基於對市場增長做出重大貢獻的地理區域。根據地區,市場分為北美、歐洲、亞太等地區。北美將在 2020 年佔據全球皮膚癌診斷和治療市場的很大份額,推動該地區增長的關鍵因素是:皮膚癌是美國□□和加拿大最常見的癌症之一。政府治療和研究疾病的努力正在推動市場增長。

本報告調查了全球皮膚癌診斷和治療藥物市場,包括市場概況、市場增長和障礙分析、市場機會、按類型/治療/診斷/地區劃分的市場規模趨勢。它提供了預測等系統信息、競爭條件和主要公司的簡介。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢

第 3 章競爭形勢

  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT 分析
  • 重要的戰略分析
  • Covid-19 對主要參與者的影響

第 4 章市場決定因素

  • 增長因素
  • 抑制因素
  • 市場機會

第 5 章市場細分

  • 按類型
    • 黑色素瘤
    • 非黑色素瘤
  • 按治療
    • 手術治療
    • 放射治療
    • 化療
    • 靶向治療
    • 免疫療法
    • 其他(激光處理、冷凍、刮除)
  • 按診斷
    • 皮膚鏡檢查
    • 活檢
    • 驗血
    • X 光
    • 其他(CT 掃瞄)

第 6 章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他領域

第 7 章公司簡介

  • Agilent technologies
  • Amgen, Inc.
  • Aqua pharmaceuticals LLC
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Bristol Myers Squibb co.
  • Daiichi Sankyo Co. Ltd.
  • Elekta AB
  • Eli Lilly and Co.
  • Glaxosmithkline PLC
  • F. Hoffmann-La Roche Ltd.
  • IcadInc.
  • Merck & co. Inc.
  • Mylan N.V.
  • Novartis InternationalAG
  • Pfizer Inc.
  • Qiagen GmbH
  • Sanofi S.A.
  • Teva pharmaceuticals Industries Ltd.
  • Varian medical systems Inc.
目錄
Product Code: OMR2023853

Full-title:Global Skin Cancer Diagnosis and Therapeutics Market Research By Type (Melanoma and Non-Melanoma), By Therapy (Surgery treatment, Radiotherapy, Chemotherapy, Targeted therapy, Immunotherapy, and Others), By Diagnosis (Dermatoscopy, Biopsy, Blood test, X-rays, and Others), Forecast, 2021-2027.

The skin cancer diagnosis and therapeutics market are anticipated to grow at a considerable CAGR of around 7.5% during the forecast period. The market is set to display impressive growth during the forecast period. The major factors that drive the market growth include the increase in the incidence of skin cancer owing to the use of artificial sunlamps, intense exposure to ultraviolet (UV) light, and tanning beds. It has been shown that the people who use a tanning bed or a sun-bed before the age of 35 years have more chances to be diagnosed with melanoma by 75%. Due to the increasing rate of skin cancer, the initiatives by the favourable government, immunotherapies, and the extension of current therapies are also increasing. 

However, the high cost of the therapy, strict regulatory environment, and the lack of awareness in the general population could hamper the market growth. According to the American cancer society, in 2021, projected 106,110 new cases of invasive melanoma and 101,280 cases of in situ melanoma are diagnosed in the US, while 7,180 people mortality from the disease. Additionally, according to WHO (World Health Organization), it is projected that more than 1,20 million cases of people across the globe are diagnosed with non-melanoma cancer in 2021. 

COVID-19 has a negative impact on the global skin cancer diagnosis and therapeutics market since December 2019.  The market is financially affected by the COVID-19. Due to the COVID-19 pandemic the skin cancer patients experience temporary delays in receiving treatment and diagnosis. The diagnosis and treatment of patients who have cancer must progress promptly. However, the growing concern of skin cancer is expected to improve the market during the forecast period. 

The global skin cancer diagnosis and therapeutics market are segmented based on type, therapy, diagnosis, and end-users. Based on type, the skin cancer diagnosis and therapeutics market is segmented into melanoma, non-melanoma. Based on therapy, the skin cancer diagnosis and therapeutics market are segmented into surgery treatment, radiotherapy, chemotherapy, targeted therapy, immunotherapy, and others. Based on the diagnosis, the skin cancer diagnosis and therapeutics market are segmented into dermatoscopy, biopsy, blood test, x-rays, and others. 

The global skin cancer diagnosis and therapeutics market are evaluated based on the geographical regions that are contributing considerably to growth towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a significant share in 2020 in the global skin cancer diagnosis and therapeutics market the major factors that drive the growth in the region are included Skin cancer is one of the most common cancer in the US and Canada. The government initiative to treat disease and research drives the growth of the market.

Research Methodology

The market study of the global Skin Cancer Diagnosis and Therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis by Type
  • Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis by Therapy
  • Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis by Diagnosis

The Report Covers

  • Comprehensive research methodology of the global Skin Cancer Diagnosis and Therapeutics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Skin Cancer Diagnosis and Therapeutics market.
  • Insights about market determinants that are stimulating the global Skin Cancer Diagnosis and Therapeutics market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Skin Cancer Diagnosis and Therapeutics Industry
  • Recovery Scenario of Global Skin Cancer Diagnosis and Therapeutics Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of Covid-19on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Skin Cancer Diagnosis and Therapeutics Market, By Type
    • 5.1.1. Melanoma
    • 5.1.2. Non-Melanoma
  • 5.2. Global Skin Cancer Diagnosis and Therapeutics Market, By Therapy
    • 5.2.1. Surgery treatment
    • 5.2.2. Radiotherapy
    • 5.2.3. Chemotherapy
    • 5.2.4. Targeted therapy
    • 5.2.5. Immunotherapy
    • 5.2.6. Others(Laser therapy, freezing, scraping)
  • 5.3. Global Skin Cancer Diagnosis And Therapeutics Market, By Diagnosis
    • 5.3.1. Dermatoscopy
    • 5.3.2. Biopsy
    • 5.3.3. Blood test
    • 5.3.4. X-rays
    • 5.3.5. Others(CT Scan)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Agilent technologies
  • 7.2. Amgen, Inc.
  • 7.3. Aqua pharmaceuticals LLC
  • 7.4. AstraZeneca PLC
  • 7.5. Bausch Health Companies Inc.
  • 7.6. Bristol Myers Squibb co.
  • 7.7. Daiichi Sankyo Co. Ltd.
  • 7.8. Elekta AB
  • 7.9. Eli Lilly and Co.
  • 7.10. Glaxosmithkline PLC
  • 7.11. F. Hoffmann-La Roche Ltd.
  • 7.12. IcadInc.
  • 7.13. Merck & co. Inc.
  • 7.14. Mylan N.V.
  • 7.15. Novartis InternationalAG
  • 7.16. Pfizer Inc.
  • 7.17. Qiagen GmbH
  • 7.18. Sanofi S.A.
  • 7.19. Teva pharmaceuticals Industries Ltd.
  • 7.20. Varian medical systems Inc.

LIST OF TABLES

  • 1. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 2. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET BY TYPE, 2020-2027 ($ MILLION)
  • 3. GLOBAL MELANOMACANCER DIAGNOSIS AND THERAPEUTICS MARKET BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL NON-MELANOMACANCER DIAGNOSIS AND THERAPEUTICS MARKET BY REGION, 2020-2027 ($ MILLION)

5. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET BY THERAPY, 2020-2027 ($ GLOBAL MILLION)

  • 6. GLOBAL SURGERY TREATMENT FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL RADIOTHERAPY FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL CHEMOTHERAPY FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL TARGETED THERAPY FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)

10. GLOBAL IMMUNOTHERAPY FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)FREEZING

  • 11. GLOBAL OTHER THERAPY FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)

12. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET BY DIAGNOSIS, 2020-2027 ($MILLION)

  • 13. GLOBAL DERMATOSCOPY FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL BLOOD TEST FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL X-RAYS FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL OTHERS DIAGNOSIS FOR SKIN CANCER MARKET BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 19. NORTH AMERICAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 20. NORTH AMERICAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 21. NORTH AMERICAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 22. EUROPEAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 23. EUROPEAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 24. EUROPEAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 25. EUROPEAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 26. ASIA-PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 27. ASIA-PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 28. ASIA-PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 29. ASIA-PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 30. REST OF THE WORLD SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 31. REST OF THE WORLD SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 32. REST OF THE WORLD SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET, 2021-2027 (%)
  • 4. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 5. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE BY THERAPY, 2020 VS 2027 (%)
  • 6. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE BY DIAGNOSIS, 2020 VS 2027 (%)
  • 7. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027, (%)
  • 8. GLOBAL MELANOMA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL NON-MELANOMA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL SURGERY TREATMENT FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL RADIOTHERAPY FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL CHEMOTHERAPY FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL TARGETED THERAPY FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL IMMUNOTHERAPY FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL OTHER THERAPY FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 16. GLOBAL DERMATOSCOPY FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL BIOPSY FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 18. GLOBAL BLOOD TEST FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 19. GLOBAL X-RAYS FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 20. GLOBAL OTHERS DIAGNOSIS FOR SKIN CANCER MARKET BY REGION, 2020 VS 2027 (%)
  • 21. US SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. CANADA MARKET SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. UK SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. GERMANY SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. SPAIN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. FRANCE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. ITALY SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. REST OF EUROPE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. INDIA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. CHINA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. JAPAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. SOUTH KOREA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. REST OF ASIA-PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. REST OF WORLD SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2020-2027 ($ MILLION)